<DOC>
	<DOCNO>NCT01742884</DOCNO>
	<brief_summary>The purpose study determine Thealoz effective Dry Eye Syndrome expose controlled adverse environmental condition .</brief_summary>
	<brief_title>Efficacy Safety Treatment Dry Eye Syndrome : Thealoz</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<criteria>Man/woman ≥ 18 year old , able freely give consent participate study Fluorescein corneal stain ≥ 1 ≤ 3 Oxford Scales At least 2 follow test alter : Ocular Surface Disease Index ( OSDI ) Test symptoms 12 40 BUT ≤10 second Lissamine green conjunctival stain ≥ 1 Schirmer Test without anesthesia ≤ 5 mm Informed consent sign Data protection consent sign Sensitivity know intolerance product use study Story ocular infection severe ocular inflammation within 6 previous month study inclusion Any active ocular pathology Dry Eye Syndrome Any traumatize ocular surgery may affect corneal sensitivity and/or normal tear distribution ( e.g . cataract surgery , refractive surgery ) within 6 previous month study inclusion Use contact lenses 3 previous month study inclusion Use ocular topical medication treatment Dry Eye Syndrome Ocular treatment Dry Eye Syndrome corticosteroid 1 month inclusion visit Cyclosporin A 3 month inclusion Diagnosis Rosacea Severe Blepharitis ( associate systemic ocular pathology ) Any severe uncontrolled systemic disease may affect eye ( except primary secondary Sjögren ) Start , discontinuation change within study dosage antihistaminics , cholinergic agent , beta blocker , anti depressant systemic drug potential effect tear film No pregnant breastfeed woman allow participate study . Childbearing potential woman must use contraceptive mean whole study . Participation another clinical trial last 30 day study inclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Dry Eye Syndrome</keyword>
</DOC>